Six minutes of intense exercise better than 30 minutes of moderate exercise in improving PPG….
Read More »Death Risk Higher in Older Diabetes Patients with Depression
More aggressive treatment of depression needed in older patients with diabetes….
Read More »Lifestyle Interventions vs. Genetic Testing in Preventing Type 2
Targeted interventions based on genetic risk may not be the best approach for preventing type 2 diabetes and instead universal strategies to prevent obesity should be prioritized….
Read More »Aspirin Delays Wound Healing
New published research describes how aspirin acts on key skin cells called keratinocytes, delaying skin repair at wound sites….
Read More »New Compound Slows Degradation of Insulin
With the discovery of a compound that can slow the degradation of insulin in mice, scientists have opened the door to a potential new treatment for diabetes….
Read More »AACE: New Guidance on Insulin Pumps
In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed….
Read More »Update: GLP-1 Analogs and Cardiovascular Health
The cardiovascular morbidity and mortality associated with diabetes are well established, so much so that type 2 diabetes has been described as a cardiovascular disease presenting as a metabolic disorder. Patients with type 2 diabetes are particularly at risk for atherosclerosis; so medications with ancillary vascular benefits are particularly useful, …
Read More »Role of the Kidneys, Part 1
This week we begin a short series of Homerun Slides on the role of the kidney. Topics covered this week include SGLT2 Inhibition, The Ominous Octet, and the Renal Handling of Glucose….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #48: Pharmacotherapy of Type 2 Diabetes, Part 7
Richard S. Beaser, MD This week’s excerpt covers the following topics: The disadvantages of triple therapy Which abnormality of the metabolic syndrome to treat first When to start triple therapy Why we need to be more aggressive in treating type 2 diabetes Achieving a Proper Balance When initiating and titrating …
Read More »NovoPen Echo
NovoPen Echo NovoPen Echo® is a new electronic insulin pen from Novo, and the first and only pen with a memory function and half‑unit dosing. The Echo records dose and time since last injection and comes with half-unit dosing from 0.5 up to 30 units. It has very short plunger movement …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.